Zomedica Corp.
ZOMDF
$0.05
$0.00142.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.61% | 10.24% | 1.84% | 14.23% | 19.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.61% | 10.24% | 1.84% | 14.23% | 19.17% |
| Cost of Revenue | 3.67% | -2.42% | -10.29% | 30.24% | 16.34% |
| Gross Profit | 9.36% | 16.00% | 7.76% | 7.35% | 20.47% |
| SG&A Expenses | -13.48% | 12.83% | 19.82% | 22.08% | 54.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.26% | 17.42% | 18.90% | 28.12% | 65.82% |
| Operating Income | 28.35% | -25.08% | -34.13% | -38.26% | -121.75% |
| Income Before Tax | 66.21% | -178.89% | -352.01% | -50.98% | -468.87% |
| Income Tax Expenses | -148.15% | 98.59% | -85.71% | -179.81% | 143.76% |
| Earnings from Continuing Operations | 67.89% | -1,263.95% | -355.92% | -43.46% | -697.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 67.89% | -1,263.95% | -355.92% | -43.46% | -697.65% |
| EBIT | 28.35% | -25.08% | -34.13% | -38.26% | -121.75% |
| EBITDA | 35.81% | -24.36% | -34.00% | -37.50% | -143.83% |
| EPS Basic | 68.12% | -1,260.00% | -351.85% | -43.08% | -689.66% |
| Normalized Basic EPS | 28.79% | -44.83% | -50.00% | -53.85% | -164.00% |
| EPS Diluted | 27.07% | -1,260.00% | -351.85% | -43.08% | -689.66% |
| Normalized Diluted EPS | 28.79% | -44.83% | -50.00% | -53.85% | -164.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |